SAN ANTONIO, Dec. 16 — The elevated breast cancer risk from hormone replacement therapy quickly dissipates after combined estrogen and progestin is discontinued, researchers reported here.
In the Women’s Health Initiative — the study that initially revealed the 24% or greater increased risk — breast cancer occurrence dropped back to pre-hormone therapy levels within a year or two after women quit therapy en masse, said Rowan T. Chlebowski, M.D., Read the rest of this entry »
American
study has revealed that high levels of insulin increase the risk of breast
cancer in women.
Lead researchers Marc Gunter and
Howard Strickler, of the Albert Einstein College of Medicine in New York,
revealed that they examined the role of insulin in breast cancer while
controlling for oestrogen levels.
This attains significance because,
while the proneness to breast cancer has been attributed to high oestrogen
levels in many obese Read the rest of this entry »
The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing Read the rest of this entry »
Akron, OH
Albuquerque, NM
Anaheim, CA
Anchorage, AK
Arlington, TX
Atlanta, GA
Aurora, CO
Austin, TX
Bakersfield, CA
Baltimore, MD
Baton Rouge, LA
Birmingham, AL
Boston, MA
Buffalo, NY
Chandler, AZ
Charlotte, NC
Chesapeake, VA
Chicago, IL
Chula Vista, CA
Cincinnati, OH
Cleveland, OH
Colorado Springs, CO
Columbus, OH
Corpus Christi, TX
Dallas, TX
Denver, CO
Detroit, MI
Durham, NC
El Paso, TX Read the rest of this entry »
researchers are studying depression in newly diagnosed breast cancer patients.
They want to learn how to spot warning signs of depression and create a screening protocol that will allow for early intervention and behavioral health treatment. Many patients believe their psychological and social needs are overlooked by their physicians during cancer treatment, according to
research.
“Too often physicians focus exclusively on patients’ Read the rest of this entry »
TUESDAY, Nov. 18 (HealthDay News) — Women whose mothers consumed canola oil during pregnancy and breast-feeding may be less likely to develop breast cancer than those whose mothers consumed corn oil, a new study suggests.
Researchers fed pregnant and lactating mice a diet high in either corn oil, which contains 50 percent omega-6 polyunsaturated fats, or canola oil, which contains only 20 percent omega-6 polyunsaturated fats. Canola oil also has Read the rest of this entry »
Studies of new uses for existing breast cancer drugs and of combinations of standard drugs with experimental ones will dominate the San Antonio Breast Cancer Symposium this week, but stock analysts say they’re not expecting major business-changing news.
Analysts say they’re not expecting any breakthrough presentations by major drugmakers at the conference, which runs Wednesday through Sunday, but say some studies are worth watching. Sponsored by Read the rest of this entry »
of breast cancer in Norwegian women suggests that some breast tumors may regress on their own over time, the
reports. The study — published Tuesday in the
— followed two groups of more than 100,000 Norwegian women ages 50 to 64 for two consecutive periods: from 1992 to 1997 and from 1996 to 2001. Norway initiated mammography screening in 1996 (Kolata,
, 11/25). Researchers compared invasive breast cancer rates among the first group — who Read the rest of this entry »
FRIDAY, Dec. 12 (HealthDay News) — Information patients commonly receive about the risk of their breast cancer returning after surgery may make their decision on whether to get chemotherapy more difficult, a new study concludes.
Doctors typically show breast cancer patients a bar chart, based on a standard risk-assessment tool, with four different post-surgery choices: hormonal therapy alone, chemotherapy alone, hormonal therapy and chemotherapy Read the rest of this entry »
The FDA has granted 510(k) clearance for Aurora Imaging Technology’s breast MR spectroscopy package aimed at enhancing the image specificity of its Aurora 1.5 Tesla system. The AuroraSPECTROSCOPY could enable users of Aurora 1.5T MR to carry out MR spectroscopic imaging and in vivo breast MR spectroscopy.
Tuesday, May 20, 2008
Monday, July 30, 2007
Tuesday, June 10, 2008
Monday, June 23, 2008
Friday, May 16, 2008
Tuesday, September 9, Read the rest of this entry »